We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: Allergy & Immunology

Unraveling Chronic Rejection in Vascularized Composite Allotransplantation: Clinical Manifestations, Mechanisms, and Future Directions

MedXY Editorial Team•Oct 24, 2025•Allergy & Immunology

Introduction

Vascularized composite allotransplantation (VCA) has revolutionized reconstructive surgery by enabling the transplantation of complex tissues including skin, muscle, bone, and nerves. Despite successes, long-term graft survival remains challenged by chronic rejection (CR), which emerges as a predominant cause of late graft failure. Unlike traditional solid organ transplants, VCAs involve multiple tissue targets, leading to diverse CR types with unique clinical and pathological features. Understanding these manifestations, underlying mechanisms, and therapeutic avenues is critical to improve outcomes.

Clinical Manifestations of Chronic Rejection in VCA

MedXY registered readers

Sign in free to continue reading

Create or use your MedXY account to unlock the complete article.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

Unveiling the TL1A-LTα1β2/IL-22 Axis: A New Therapeutic Target in Crohn’s Disease with Perianal Fistulising DiseaseThis study reveals that TL1A-activated CD4+ T cells drive distinct cellular and molecular changes in the rectal mucosa of Crohn’s disease patients with perianal fistulising disease (PFD), highlighting a novel TL1A-LTα1β2/IL-22 axis inSep 19, 2026Rademikibart and Eosinophil Counts in Moderate-to-Severe Asthma: Insights from a Phase 2b Randomized TrialThis article reviews exploratory analyses from a phase 2b trial examining eosinophil count changes in adults with uncontrolled moderate-to-severe asthma treated with the IL-4Rα inhibitor rademikibart, indicating a low risk of treatment-emerSep 18, 2026Tezepelumab Demonstrates Robust Efficacy and Safety Across Diverse Severe Asthma Phenotypes: Insights from the Phase 4 PASSAGE StudyThe PASSAGE phase 4 study reveals tezepelumab significantly reduces exacerbation rates and improves lung function and quality of life in a broad US severe asthma population, including underrepresented groups and varied phenotypes.Sep 12, 2026
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
Nonvascularized Rectus Fascia Allografts: A Novel Cross-Disciplinary Approach for Complex Abdominal and Thoracic Reconstruction
This study evaluates nonvascularized rectus fascia allotransplantation (NVRF-alloTx) as an effective, versatile reconstructive option in both solid organ transplant and non-transplant patients, demonstrating promising integration and functi
Sep 8, 2026
Unraveling Genetic Pathways in Type 1 Diabetes: Distinct HLA-DR3 and DR4 Effects on Disease ProgressionThis study reveals that genetic risk factors and immune pathways differ significantly between type 1 diabetes patients stratified by HLA-DR3 and HLA-DR4 status, providing insights into disease heterogeneity and personalized risk mechanisms.Sep 5, 2026
HPV-Associated Anal Dysplasia in Solid Organ Transplant Recipients: Exploring Transplant-Specific Mucosal Immune DysregulationSolid organ transplant recipients exhibit heightened risk for HPV-associated anal dysplasia and cancer due to unique immunosuppressive alterations. A transplant-tailored model of mucosal immune dysfunction elucidates mechanisms driving persSep 3, 2026